View all data FOR FREE!
Create an account today, no credit card required.
| Issue Type | XXXX |
|---|---|
| Country | United States |
| Industry | XXXX |
| Region | XXXX |
| Maturity Date | 2029-06-01 |
| Par Value | 100000 |
| Callable | XXXX |
| Next Call Date | XXXX |
| Call Type | XXXX |
| Call Price (%) | XXXX |
| Series | XXXX |
| Class | XXXX |
| Maturity Structure | XXXX |
| Amount Outstanding (mil) | 36.46 |
| Coupon | 2.125 |
|---|---|
| Coupon Type | XXXX |
| Coupon Frequency | XXXX |
| First Coupon Date | XXXX |
| Last Coupon Date | XXXX |
| Sinking Fund | XXXX |
|---|---|
| Security | XXXX |
| Subordination | XXXX |
| Debt Type | XXXX |
| Issue Date | XXXX |
|---|---|
| Dated Date | XXXX |
| Issue Size (mil) | 550.000 |
| Min. Piece | XXXX |
| Min. Increment | XXXX |
This Allergan Funding SCS. corporate note has a 2.13% fixed rate coupon paid on a annual basis. It was issued on May 26, 2017 with an issue size of 550.00 million EUR and matures on June 01, 2029 with a last coupon date of June 01, 2028. |
Allergan Funding SCS, headquartered in Luxembourg, was founded to facilitate financing for its parent company, Allergan, in the healthcare sector. The company focuses primarily on raising capital through bond issuance to support Allergan's various business operations and product developments.